Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pharma Bio Serv Inc (OP: PBSV )

0.5815 -0.0080 (-1.36%)
Streaming Delayed Price Updated: 2:22 PM EST, Feb 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pharma Bio Serv Inc

Pharma-Bio Serv Announces Full Year Results
Via ACCESS Newswire
Pharma-Bio Serv Announces Special Dividend
Via ACCESS Newswire
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2024
Via ACCESSWIRE
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2024
Via ACCESSWIRE
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2024
Via ACCESSWIRE
Pharma-Bio Serv Announces Full Year Results
Via ACCESSWIRE
Pharma-Bio Serv Announces Special Dividend
Via ACCESSWIRE
Pharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2023
Via ACCESSWIRE
Pharma-Bio Serv Announces Results for the Three and Six Months Ended April 30, 2023
Via ACCESSWIRE
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2023
Via ACCESSWIRE
Pharma-Bio Serv Announces Special Dividend
Via ACCESSWIRE
Pharma-Bio Serv Retains Investment Banking Firm ACP Capital to Provide Investment Banking and M&A Advisory Services
Via ACCESSWIRE
Pharma-Bio Serv Announces Full Year Results
Via ACCESSWIRE
Pharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2022
Via ACCESSWIRE
Pharma-Bio Serv Announces Results for the Three and Six Months Ended April 30, 2022
DORADO, PUERTO RICO / ACCESSWIRE / June 14, 2022 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting... 
From Pharma-Bio Serv Inc.
Via AccessWire
Topics Economy
Exposures Economy Product Safety
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2022
DORADO, PUERTO RICO / ACCESSWIRE / March 17, 2022 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting... 
From Pharma-Bio Serv Inc.
Via AccessWire
Pharma-Bio Serv Announces Full Year Results and Declares a Special Dividend
DORADO, PUERTO RICO / ACCESSWIRE / February 11, 2022 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory, compliance, project management and technology transfer... 
From Pharma-Bio Serv Inc.
Via AccessWire
Pharma-Bio Serv Announces Special Dividend
DORADO, PUERTO RICO / ACCESSWIRE / November 15, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory, compliance, project management and technology transfer... 
From Pharma-Bio Serv Inc.
Via AccessWire
Exposures COVID-19 Product Safety
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2021
DORADO, PUERTO RICO / ACCESSWIRE / September 14, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory, compliance, project management and technology transfer... 
From Pharma-Bio Serv Inc.
Via AccessWire
Exposures Product Safety
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2021
Announces Regulatory and Compliance Advisory Board DORADO, PUERTO RICO / ACCESSWIRE / June 14, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project... 
From Pharma-Bio Serv Inc.
Via AccessWire
Exposures Product Safety
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.